David Kirsch
Barbara Levine University Distinguished Professor · Duke University Hospital
Credentials: · · · ·
History
Present
- 2000–2001
Preliminary or Transitional Year
- 1996–2000
Research
Restoration of p53 function leads to tumour regression in vivo
Nature · 2007 · 1,534 citations
Conversion of Bcl-2 to a Bax-like death effector by caspases
Science · 1997 · 940 citations
Metabolomics in cancer research and emerging applications in clinical oncology
Review · Current Anthropology · 2021 · 568 citations
28 papers
27 papers · 5 as a resident
24 papers · 4 as a resident
19 papers
19 papers
19 papers · 5 as a resident
- AW
18 papers · 10 as a resident
- JM
16 papers · 13 as a resident
Grants
- 2024–2029
National Institute of Allergy and Infectious Diseases · U01
PI · $1M · Duke University
- 2016–2029
Advancing Cancer Therapy Through Groundbreaking Research in Radiation Biology
National Cancer Institute · R35
Contact PI · $10.7M · Roswell Park Cancer Institute Corp
- 2005–2026
Centers for Medical Countermeasures Against Radiation
National Institute of Allergy and Infectious Diseases · U19
Project lead · $3.5M · Duke University
- 1997–2025
Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $313.8K · Duke University
Clinical trials
- 2008–2018
Study chair · Completed · Phase 2
Radiation Therapy Oncology Group